🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to compare the procedures for the collection P...
Status
Completed
Location
Bonfils Blood Center
Start Date
2013-02
Trial ID
NCT01805180
The primary objective is to determine whether donor stem cells administered...
Status
Withdrawn
Location
Multiple Locations
Start Date
2002-05
Trial ID
NCT00062543
Treatments Being Tested
Beyond supportive care, there are currently no proven treatment options for...
Status
Completed
Location
Pak Emirates Military Hospital
Start Date
2020-04-01
Trial ID
NCT04492501
The purpose of this prospective, randomized, cross-over, multi-center study...
Status
Completed
Location
Hoxworth Blood Center
Start Date
2014-09
Trial ID
NCT02253160
Treatments Being Tested
To investigate the efficacy and safety of autologous peripheral blood stem ...
Status
Withdrawn
Location
SeoulNUH
Start Date
2014-05
Trial ID
NCT02315235
Treatments Being Tested
Experimental Use of Convalescent Plasma of Passive Immunisation In Current ...
Status
Unknown
Location
National Institute of Blood Diseases and Bone Marrow Transplantation (NIBD)
Start Date
2020-05-01
Trial ID
NCT04352751
Treatments Being Tested
The purpose of this investigation is to establish that hematopoetic stem ce...
Status
Completed
Location
Emory University
Start Date
2011-02
Trial ID
NCT01292486
Treatments Being Tested
Background: investigators have seen recently from experience in Western co...
Status
Completed
Location
Pak Emirates Military Hospital
Start Date
2020-04-01
Trial ID
NCT04485169
Treatments Being Tested
Multiple sclerosis is an autoimmune disease. We are studying whether high d...
Status
Completed
Location
Ottawa Hospital Research Institute
Start Date
2001-08
Trial ID
NCT01099930
The primary focus of the trial is safety and efficacy of the intra-muscular...
Status
Completed
Location
Patricia LEMARCHAND
Start Date
2004-10
Trial ID
NCT00533104
Treatments Being Tested